![Aaron Royston](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aaron Royston
Director/Board Member at
ATTOVIA THERAPEUTICS, INC.
Profile
Aaron E.
Royston was the founder of Red Ventures LLC, founded in 2010, and Rayzebio, Inc., founded in 2020 where the title held was Director from 2020 to 2023.
Current jobs include Board of Directors at HistoWiz, Inc. since 2021; Board Of Director at Swift Health Systems, Inc. since 2019; Director at Neurogastrx, Inc. since 2018; Director at Abbott Pharmaceuticals (Shanghai) Co., Ltd.; Director at Ceptur Therapeutics, Inc.; Director at 35Pharma, Inc. since 2022; Independent Director at Achieve Life Sciences, Inc. starting 2026; Independent Director at Attovia Therapeutics, Inc. since 2023; and Managing Partner at venBio Partners LLC since 2015.
Former jobs include Director at IPI Legacy Liquidation Co. from 2016 to 2021; Independent Director at Menlo Therapeutics, Inc. from 2017 to 2019; Director at Harmony Biosciences Holdings, Inc.; Director at Harmony Biosciences LLC; Independent Non-Executive Director at Akero Therapeutics, Inc. from 2018 to 2019; Independent Director at Ventyx Biosciences, Inc. from 2021 to 2023; and Board of Directors at Apellis Pharmaceuticals, Inc. Education includes undergraduate degree from Duke University and MBA and doctorate degrees from the University of Pennsylvania.
Aaron Royston active positions
| Companies | Position | Start |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Director/Board Member | 31/05/2023 |
| ACHIEVE LIFE SCIENCES, INC. | Director/Board Member | 16/04/2026 |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Private Equity Investor | 31/12/2014 |
Swift Health Systems, Inc.
 Swift Health Systems, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which develops invisible orthodontic solutions | Director/Board Member | 06/01/2019 |
HistoWiz, Inc.
 HistoWiz, Inc. Packaged SoftwareTechnology Services Develops information technologies to archive and manage multi-terabyte databases for histopathology services | Director/Board Member | 30/09/2021 |
35Pharma, Inc.
 35Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in designing and developing of TGF-beta superfamily therapeutics | Director/Board Member | 31/10/2022 |
Ceptur Therapeutics, Inc.
 Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic medicines | Director/Board Member | - |
Ablaze Pharmaceuticals
 Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of radiopharmaceutical therapies to treat cancer patients | Director/Board Member | - |
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Director/Board Member | 03/01/2018 |
Former positions of Aaron Royston
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Aaron Royston
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
HistoWiz, Inc.
HistoWiz, Inc. Packaged SoftwareTechnology Services Develops information technologies to archive and manage multi-terabyte databases for histopathology services | Technology Services |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Red Ventures LLC
 Red Ventures LLC Advertising/Marketing ServicesCommercial Services Operates as a digital experience and brand development platform & provides investment services | Commercial Services |
venBio Partners LLC
venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Finance |
Swift Health Systems, Inc.
Swift Health Systems, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which develops invisible orthodontic solutions | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of radiopharmaceutical therapies to treat cancer patients | Health Technology |
Ceptur Therapeutics, Inc.
Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic medicines | Health Technology |
35Pharma, Inc.
35Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in designing and developing of TGF-beta superfamily therapeutics | Health Technology |
Attovia Therapeutics
 Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
- Stock Market
- Insiders
- Aaron Royston
